TRAVERE THERAPEUTICS, INC.: accounts_receivable

Value{"amount": 14675000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2022-03-31)
Statuscurrent
EntityTRAVERE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001438533-22-000025
Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001438533/accounts-receivable/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/3c0e9c2f-a703-4827-a031-aba924e9d88d

History